Duopharma Biotech Berhad, the distributor of the Sinopharm vaccine, was one of the winners of the pandemic. But with a price cap set by the government, how will that impact the company? Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd answers those questions and their strategy for growth.

Produced by: Moh Heng Ying

Presented by: Wong Shou Ning

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  duopharma,  sinopharm,  duopharma biotech,  vaccines,  pharmaceuticals,  Aviation, Auto, Transport, Logistics,  Media, Marketing, Advertising,  Commodities, Agribusiness,  Healthcare, Pharma, Biotech,  Telecom, IT, Technology,  Politics, News, Current Affairs,  Economy, Markets,  CEO/Business leaders,  Health,  social issues,  business analysis,  trends and forecasts,  diseases and conditions,  healthy living,  health policy,  medical innovation and technology